IGC vs PATH
India Globalization Capital Inc (IGC) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
India Globalization Capital Inc (IGC) is a biotechnology company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IGC revenue for 2025-03-31 was $1.3M. Net income was -$7.1M. Revenue was down 5.5% from 2024-03-31 to 2025-03-31. IGC currently screens at market cap $24.1M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IGC currently screens at market cap $24.1M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IGC and PATH stock pages for the full models.
Not investment advice.